ORLANDO, Fla.-- (BUSINESS WIRE)-- LENSAR, Inc., a global leader in next-generation femtosecond laser technology for refractive cataract surgery, today announced it has received the CE Mark from ...

LensAR has announced it has received FDA 510(k) clearance for company’s next-generation LensAR Laser System for use in anterior capsulotomy, with and without laser phacofragmentation during cataract ...

LensAR has announced cataract surgeons have completed the first laser cataract surgeries using the company’s LensAR laser system, according to a news release. Cataract surgeons David W. Shoemaker, MD, ...

In a typical laser-assisted cataract surgery, the procedure is split between a laser suite and an operating room. Lensar, however, set its sights on building an all-in-one system that could allow the ...

ORLANDO, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of ...

These proprietary features provide new opportunities for surgeons in laser cataract surgery procedures. About LENSAR LENSAR is a commercial-stage medical device company focused on designing, ...

(RTTNews) - LENSAR, Inc. (LNSR), a commercial-stage medical device company, announced FDA 510(k) clearance for next-generation ALLY Adaptive Cataract Treatment System. ALLY is the first FDA-cleared ...

Please provide your email address to receive an email when new articles are posted on . Lensar received FDA 510(k) clearance for its next-generation Ally adaptive cataract treatment system, according ...

Shares of eye care company Alcon AG (NYSE:ALC) are trading higher on Monday. The company has agreed to acquire LENSAR Inc (NASDAQ:LNSR), a firm recognized for its laser solutions in cataract surgery.

US firm's dual-pulsed femtosecond laser now under FDA review, with plans to launch later this year. The CEO of Florida-based Lensar, which has developed a new ultrafast laser system for cataract ...

Alcon, the multinational pharmaceuticals company specializing in eye care, has agreed a deal to acquire cataract laser surgery pioneer Lensar. The deal, valued at up to $430 million, will expand Alcon ...

ORLANDO, Fla.--(BUSINESS WIRE)-- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today ...